European regulators have approved MSD’s Prevymis for the prevention of cytomegalovirus (CMV) reactivation and disease in prone adults who have received an allogeneic haematopoietic stem cell transplant (HSCT). More: EU clears MSD’s Prevymis for CMV prevention Source: News
read moreA charity survey has highlighted an “urgent need” for earlier diagnosis of kidney cancer, revealing that, in 51 percent of cases, the disease is detected from scans relating to other health conditions. More: Survey reveals low awareness of kidney cancer
read moreSanofi, which has been converting its biologics plant in Framingham, Massachusetts, to digital manufacturing, will again expand the facility. More: Sanofi expands U.S. biologics plant even as it strikes deals to stuff its pipeline Source: fierce
read moreDid insider trading occur around Sanofi’s $11.6 billion deal for Bioverativ? The Securities and Exchange Commission thinks it may have—and it’s suing on that suspicion. More: SEC sues over suspected insider trading around Sanofi's Bioverativ buy Source: fierce
read moreCelgene Chairman Bob Hugin handed the CEO baton to Mark Alles in 2016, but he retained serious influence at the company—and in the biotech industry overall. Now, he’s bidding goodbye to the company he joined 19 years ago. Up next?
read moreNovartis and Bayer executives were among a list of attendees at a private dinner in Davos with U.S. President Donald Trump. More: Novartis, Bayer CEOs get time with Trump as he meets with EU business leaders during Davos trip Source:
read more© 1994 - 2026 B.M. Pharmaceuticals